The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Levy Adam D. since 2026.
This trader's CIK number is 2061876.
At the time of last reporting, Levy Adam D. was the Chief Financial Officer of Acrivon Therapeutics, Inc.. (stock ticker symbol ACRV).
Also see all insider trading activities at Acrivon Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | ACRV | 8,832 | $14,996 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-01-14 | ACRV | Buy | 8,832 | 1.70 | 14,996 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Levy Adam D. (Chief Financial Officer of Acrivon Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.